Emerging therapies for the treatment of hepatitis C

Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introduction of interferon-α monotherapy in 1992 to the approval of telaprevir- and boceprevir-based triple therapies with pegylated interferon-α and ribavirin in 2011, the chances of curing patients infecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Christian M, Jacobson, Ira M, Rice, Charles M, Zeuzem, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936496/
https://www.ncbi.nlm.nih.gov/pubmed/24106239
http://dx.doi.org/10.1002/emmm.201303131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936496/
https://www.ncbi.nlm.nih.gov/pubmed/24106239
http://dx.doi.org/10.1002/emmm.201303131

Ejemplares similares